Drugs / Boostrix-inactivated poliovirus vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03908164 | May 2019 → Dec 2020 | pertussis, pregnancy disorder | St George's, University of London | Unknown | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Boostrix-inactivated poliovirus vaccine | “participants were randomly assigned (1:1:1 ratio) to receive a pertussis-containing vaccine (Boostrix-inactivated poliovirus vaccine) in one of three gestational age groups” PMID 37080224 ↗ Apr 2023 |
| Modality | Vaccine | “participants were randomly assigned (1:1:1 ratio) to receive a pertussis-containing vaccine (Boostrix-inactivated poliovirus vaccine)” PMID 37080224 ↗ Apr 2023 |